Press "Enter" to skip to content

Posts tagged as “phase”

ADC Therapeutics Doses First Patients in Pivotal Phase 2 Clinical Trial of ADCT-301 in Patients with Relapsed or Refractory Hodgkin Lymphoma – BioSpace

admin 0

ADC Therapeutics Doses First Patients in Pivotal Phase 2 Clinical Trial of ADCT-301 in Patients with Relapsed or Refractory Hodgkin Lymphoma  BioSpace “lymphoma cancer” – Google News

Isofol Receives Positive Feedback From PMDA in Japan, Expanding Ongoing Global Pivotal Phase 3 AGENT Trial in First Line Metastatic Colorectal Cancer – BioSpace

admin 0

Isofol Receives Positive Feedback From PMDA in Japan, Expanding Ongoing Global Pivotal Phase 3 AGENT Trial in First Line Metastatic Colorectal Cancer  BioSpace “colorectal cancer” – Google News

Isofol Receives Positive Feedback From PMDA in Japan, Expanding Ongoing Global Pivotal Phase 3 AGENT Trial in First Line Metastatic Colorectal Cancer – PRNewswire

admin 0

Isofol Receives Positive Feedback From PMDA in Japan, Expanding Ongoing Global Pivotal Phase 3 AGENT Trial in First Line Metastatic Colorectal Cancer  PRNewswire “colorectal cancer” – Google News

Ultra-Hypofractionated Radiation Therapy for Unfavorable Intermediate-Risk and High-Risk Prostate Cancer is Safe and Effective: 5-year Outcomes of a Phase II Trial. – UroToday

admin 0

Ultra-Hypofractionated Radiation Therapy for Unfavorable Intermediate-Risk and High-Risk Prostate Cancer is Safe and Effective: 5-year Outcomes of a Phase II Trial.  UroToday “prostate cancer” – Google News

Hepagene Therapeutics, Inc, Announces Dosing of First Healthy Subject in a Phase I Study of HPG1860 for NASH | Small Molecules | News Channels – PipelineReview.com

admin 0

Hepagene Therapeutics, Inc, Announces Dosing of First Healthy Subject in a Phase I Study of HPG1860 for NASH | Small Molecules | News Channels  PipelineReview.com “liver cancer” – Google News

Can-Fite and Gebro Pharma holding European Conference on Development & Commercialization of Phase III Drug Candidate Piclidenoson in the Treatment of Rheumatoid Arthritis – Yahoo Finance

admin 0

Can-Fite and Gebro Pharma holding European Conference on Development & Commercialization of Phase III Drug Candidate Piclidenoson in the Treatment of Rheumatoid Arthritis  Yahoo Finance “liver cancer” – Google News

ADC Therapeutics Doses First Patients in Pivotal Phase 2 Clinical Trial of ADCT-301 in Patients with Relapsed or Refractory Hodgkin Lymphoma – Yahoo Finance

admin 0

ADC Therapeutics Doses First Patients in Pivotal Phase 2 Clinical Trial of ADCT-301 in Patients with Relapsed or Refractory Hodgkin Lymphoma  Yahoo Finance “lymphoma cancer” – Google News

SurgiMab Recruits First US Patient in Pivotal Phase 3 Trial Evaluating SGM-101, a Novel Fluorescent Tumor-specific Antibody, for the Improvement of Surgical Outcomes in Colorectal Cancer Patients – PRNewswire

admin 0

SurgiMab Recruits First US Patient in Pivotal Phase 3 Trial Evaluating SGM-101, a Novel Fluorescent Tumor-specific Antibody, for the Improvement of Surgical Outcomes in Colorectal Cancer Patients  PRNewswire “colorectal cancer” –…

Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial – The Lancet

admin 0

Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial  The Lancet “prostate cancer”…